Earnings Preview: Eli Lilly (LLY) Q3 Earnings Expected to Decline

Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

22.10.2026

Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020

First Lilly site to produce both active pharmaceutical ingredients and finished medicines in a fully integrated facility Site will create 650 high-wage jobs INDIANAPOLIS, Oct. 22, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) broke ground today on a new $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County, one of 10 new U.S. manufacturing sites announced since 2020 and one of five among them that will produce active pharmaceutical ingredients (API). As part of the company's more than $50 billion push to expand medicine production in the U.S., the Richmond site will be Lilly's first to produce both API and finished medicines in a fully integrated facility, with dedicated API capacity for bioconjugate and large-molecule medicines.

22.10.2026

Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?

Bristol Myers Squibb (BMY -0.91%) primarily generates its revenue by developing and selling prescription therapeutic medications for oncology and cardiovascular health worldwide.

21.10.2026

7 healthcare stocks that stand out as investors pay up for the sector

Investors have pushed the healthcare sector to a record high, and some favored stocks have high projected revenue growth rates through 2028.

21.10.2026

Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss

Novo Nordisk's CagriSema delivers 25% weight loss in women, spotlighting three ETFs for diversified exposure to the sector's growth.

21.10.2026

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.

21.10.2026

Here's What I'm Planning With My Eli Lilly Position

Business is booming, and the pipeline of new treatments is robust.

Видео

22.09.2026

Positive

Ken Langone on Eli Lilly: Could be a $2,000 stock in the next 3-4 years

18.09.2026

Positive

40% of U.S. Adults to Use GLP-1s? Raul Shah on LLY, NVO & Weight Loss "Mania"

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
LLY	Berenberg	Buy	undefined >> $1,400	September 15th 2026

Пресс-релизы

22.10.2026

Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020

Eli Lilly and Company (LLY)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Контакты

Мы в соцсетях

Eli Lilly and Company (LLY)

Earnings Preview: Eli Lilly (LLY) Q3 Earnings Expected to Decline

Lilly breaks ground in Richmond to expand American manufacturing of next-generation cancer medicines, advancing its build-out of 10 new U.S. sites since 2020

Bristol Myers Squibb vs. Eli Lilly: How Long Can Zepbound and Mounjaro Keep Juicing Revenue Results?

7 healthcare stocks that stand out as investors pay up for the sector

Obesity ETFs to Gain as Novo's CagriSema Shows 25% Weight Loss

Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know